telmisartan has been researched along with AIDS-Associated Nephropathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chander, PN; Charney, DN; Ding, G; Kumar, D; Singhal, PC; Vallabu, S; Yadav, A | 1 |
Adabala, M; Chander, PN; Ding, G; Husain, M; Kumar, D; Maheshwari, S; Malhotra, A; Rai, P; Rattanavich, R; Sagar, A; Salhan, D; Singhal, PC | 1 |
2 other study(ies) available for telmisartan and AIDS-Associated Nephropathy
Article | Year |
---|---|
HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.
Topics: Actins; AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cadherins; Calcium-Binding Proteins; Cell Proliferation; Cell Transdifferentiation; Disease Models, Animal; Epithelial Cells; Fibroblasts; HIV-1; Infusions, Subcutaneous; Kidney Glomerulus; Kidney Tubules; Macrophages; Mice; Mice, Transgenic; Phenotype; Podocytes; Proliferating Cell Nuclear Antigen; Receptor, Angiotensin, Type 1; RNA, Messenger; S100 Calcium-Binding Protein A4; S100 Proteins; T-Lymphocytes; Telmisartan | 2010 |
HIV-associated nephropathy: role of AT2R.
Topics: AIDS-Associated Nephropathy; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Humans; Imidazoles; Kidney Glomerulus; Mice; Mice, Transgenic; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Telmisartan | 2012 |